1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Global Neurostimulation Devices Market 2015

Global Neurostimulation Devices Market 2015

  • June 2015
  • -
  • Infiniti Research Limited
  • -
  • 83 pages

About Neurostimulation Devices
Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson’s disease, and depression are not sufficient for all patients at all stages of treatment. More than 100 million people suffer from these conditions in the US alone. Though drug therapy, physiotherapy, and surgeries are effective treatment options, they are not suitable for all patients. For example, approximately 15-20% of epilepsy patients are drug-resistant and require alternate treatment method. Neurostimulation is a potential alternative for patients for whom the drug therapy or surgery is not effective.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
Technavio's analysts forecast the global neurostimulation devices market to grow at a CAGR of 5.37% over the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global neurostimulation devices market for the period 2015-2019. Based on devises, the market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others.
Technavio's report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global neurostimulation devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Boston Scientific
• Cyberonics
• Medtronic
• St. Jude Medical
Other Prominent Vendors

• Aleva Neurotherapeutics
• Atrotech
• Autonomic Technologies
• ElectroCore
• Endostim
• EnteroMedics
• ImThera Medical
• Inspire Medical Systems
• Neuros Medical
• NeuroMetrix
• NeuroPace
• NeuroSigma
• Nevro
• SPR Therapeutics
• Synapse Biomedical

Market Driver
• Rise in Prevalence of Neurological Disorders
• For a full, detailed list, view our report

Market Challenge
• Not First Line of Treatment Therapy
• For a full, detailed list, view our report

Market Trend
• Significant Increase in Product Development and Launches
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Neurostimulation Devices Market 2015
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
05.1 Basic Components of Neurostimulation Devices
05.2 Generator
05.3 Leads
05.4 Programmer
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Rechargeable and Non-rechargeable Neurostimulation Devices
06.4 Five Forces Analysis
07. Market Segmentation by Systems
07.1 Global SCS Systems Market
07.1.1 Market Size and Forecast
07.2 Global DBS Systems Market
07.2.1 Market Size and Forecast
07.3 Global SNS Systems Market
07.3.1 Market Size and Forecast
07.4 Global VNS Systems Market
07.4.1 Market Size and Forecast
08. Geographical Segmentation
08.1 Neurostimulation Devices Market in Americas
08.1.1 Market Size and Forecast
08.2 Neurostimulation Devices Market in EMEA
08.2.1 Market Size and Forecast
08.3 Neurostimulation Devices Market in the APAC
08.3.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2014
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Medtronic
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation
17.1.4 Revenue by Business Segmentation
17.1.5 Revenue Comparison by Business Segmentation 2012 and 2013
17.1.6 Revenue by Geographical Segmentation
17.1.7 Business Strategy
17.1.8 Key Developments
17.1.9 SWOT Analysis
17.2 Boston Scientific
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation
17.2.4 Business Segmentation by Revenue 2013
17.2.5 Business Segmentation by Revenue 2012 and 2013
17.2.6 Geographical Segmentation by Revenue 2013
17.2.7 Business Strategy
17.2.8 Recent Developments
17.2.9 SWOT Analysis
17.3 St. Jude Medical
17.3.1 Key Facts
17.3.2 Business Description
17.3.3 Business Segmentation
17.3.4 Business Strategy
17.3.5 Revenue Segmentation by Business
17.3.6 Revenue by Geographical Segmentation
17.3.7 Key Information
17.3.8 SWOT Analysis
17.4 Cyberonics
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Geographical Segmentation by Revenue 2014
17.4.4 Business Strategy
17.4.5 Recent Developments
17.4.6 SWOT Analysis
18. Other Reports in this Series




List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Components of Neurostimulation Devices
Exhibit 3: Global Neurostimulation Devices Market 2014-2019 ($ Millions)
Exhibit 4: Segmentation of Global Neurostimulation Devices Market by Systems
Exhibit 5: Segmentation of Global Neurostimulation Devices Market by Systems 2014
Exhibit 6: Global SCS Systems Market 2014-2019 ($ Millions)
Exhibit 7: Cost Distribution in Parkinson's Disease
Exhibit 8: Global DBS Systems Market 2014-2019 ($ Millions)
Exhibit 9: Global SNS Systems Market 2014-2019 ($ Millions)
Exhibit 10: Global VNS System Market 2014-2019 ($ Millions)
Exhibit 11: Segmentation of Global Neurostimulation Devices Market by Systems 2014-2019
Exhibit 12: Segmentation of Global Neurostimulation Devices Market by Systems 2014-2019 ($ Millions)
Exhibit 13: Snapshot of Global Neurostimulation Devices Market 2014-2019
Exhibit 14: Segmentation of Global Neurostimulation Devices Market by Geography in 2014
Exhibit 15: Common Conditions That Use Neurostimulation Devices
Exhibit 16: Disease Economic Burden in the US
Exhibit 17: Neurostimulation Devices Market in the Americas 2014-2019 ($ Millions)
Exhibit 18: Neurostimulation Devices Market in EMEA 2014-2019 ($ Millions)
Exhibit 19: Neurostimulation Devices Market in APAC 2014-2019 ($ Millions)
Exhibit 20: Segmentation of Global Neurostimulation Devices Market by Geography in 2014-2019
Exhibit 21: Segmentation of Global Neurostimulation Devices Market by Geography in 2014-2019 ($ Millions)
Exhibit 22: Global Neurostimulation Devices Market Share Analysis 2014
Exhibit 23: Key Takeaways: Medtronic
Exhibit 24: Key Takeaways: Boston Scientific
Exhibit 25: Key Takeaways: St. Jude Medical
Exhibit 26: Key Takeaways: Cyberonics
Exhibit 27: Medtronic Inc.: Business Segmentation
Exhibit 28: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 29: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 30: Medtronic Inc.: Revenue by Geographical Segmentation 2013
Exhibit 31: Boston Scientific: Business Segmentation
Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 33: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 35: St. Jude Medical: Business Segmentation
Exhibit 36: St. Jude Medical: Revenue by Business Segmentation 2013
Exhibit 37: St. Jude Medical: Revenue by Geographical Segmentation 2012
Exhibit 38: Cyberonics: Geographical Segmentation by Revenue 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Brain Injury in 21 Major Markets Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.